Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study.

Chollet-Hinton L, Anders CK, Tse CK, Bell MB, Yang YC, Carey LA, Olshan AF, Troester MA.

Breast Cancer Res. 2016 Aug 4;18(1):79. doi: 10.1186/s13058-016-0736-y.

2.

Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer.

Jones LW, Habel LA, Weltzien E, Castillo A, Gupta D, Kroenke CH, Kwan ML, Quesenberry CP Jr, Scott J, Sternfeld B, Yu A, Kushi LH, Caan BJ.

J Clin Oncol. 2016 Aug 10;34(23):2743-9. doi: 10.1200/JCO.2015.65.6603. Epub 2016 May 23.

PMID:
27217451
3.

Dedicated Three-dimensional Breast Computed Tomography: Lesion Characteristic Perception by Radiologists.

Kuzmiak CM, Cole EB, Zeng D, Tuttle LA, Steed D, Pisano ED.

J Clin Imaging Sci. 2016 Mar 30;6:14. doi: 10.4103/2156-7514.179428. eCollection 2016.

4.

Bilateral Mastectomy for Unilateral Breast Cancer: a Perplexing Trend.

Jatoi I.

Indian J Surg Oncol. 2015 Dec;6(4):387-9. doi: 10.1007/s13193-015-0450-8. Epub 2015 Aug 1.

PMID:
27081256
5.

CDDO-Me Redirects Activation of Breast Tumor Associated Macrophages.

Ball MS, Shipman EP, Kim H, Liby KT, Pioli PA.

PLoS One. 2016 Feb 26;11(2):e0149600. doi: 10.1371/journal.pone.0149600. eCollection 2016.

6.

Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer.

Schummer M, Thorpe J, Giraldez MD, Bergan L, Tewari M, Urban N.

PLoS One. 2015 Nov 13;10(11):e0142911. doi: 10.1371/journal.pone.0142911. eCollection 2015. Erratum in: PLoS One. 2016;11(1):e0147561. Giraldez, Maria [corrected to Giraldez, Maria D].

7.

Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.

Howlader N, Morton LM, Feuer EJ, Besson C, Engels EA.

Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):174-9. doi: 10.1158/1055-9965.EPI-15-0921. Epub 2015 Oct 15.

PMID:
26472423
8.

A retrospective analysis of breast cancer subtype based on ER/PR and HER2 status in Ghanaian patients at the Korle Bu Teaching Hospital, Ghana.

Seshie B, Adu-Aryee NA, Dedey F, Calys-Tagoe B, Clegg-Lamptey JN.

BMC Clin Pathol. 2015 Jul 9;15:14. doi: 10.1186/s12907-015-0014-4. eCollection 2015.

9.

Effect of radiotherapy on survival of women with locally excised ductal carcinoma in situ of the breast: a Surveillance, Epidemiology, and End Results population-based analysis.

Qian GW, Ni XJ, Wang Z, Jiang YZ, Yu KD, Shao ZM.

Onco Targets Ther. 2015 Jun 10;8:1407-18. doi: 10.2147/OTT.S82087. eCollection 2015.

10.

Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study.

Tao L, Gomez SL, Keegan TH, Kurian AW, Clarke CA.

Cancer Epidemiol Biomarkers Prev. 2015 Jul;24(7):1039-45. doi: 10.1158/1055-9965.EPI-15-0243. Epub 2015 May 12.

11.

Soy isoflavone intake and bone mineral density in breast cancer survivors.

Baglia ML, Gu K, Zhang X, Zheng Y, Peng P, Cai H, Bao PP, Zheng W, Lu W, Shu XO.

Cancer Causes Control. 2015 Apr;26(4):571-80. doi: 10.1007/s10552-015-0534-3. Epub 2015 Feb 17.

12.

Rapid reduction in breast cancer mortality with inorganic arsenic in drinking water.

Smith AH, Marshall G, Yuan Y, Steinmaus C, Liaw J, Smith MT, Wood L, Heirich M, Fritzemeier RM, Pegram MD, Ferreccio C.

EBioMedicine. 2014 Nov 1;1(1):58-63.

13.

When do changes in cancer survival mean progress? The insight from population incidence and mortality.

Cho H, Mariotto AB, Schwartz LM, Luo J, Woloshin S.

J Natl Cancer Inst Monogr. 2014 Nov;2014(49):187-97. doi: 10.1093/jncimonographs/lgu014.

14.

Trends in 5-year survival rates among breast cancer patients by hormone receptor status and stage.

Chen L, Linden HM, Anderson BO, Li CI.

Breast Cancer Res Treat. 2014 Oct;147(3):609-16. doi: 10.1007/s10549-014-3112-6. Epub 2014 Aug 28.

15.

Estrogen receptor-alpha 36 mediates the anti-apoptotic effect of estradiol in triple negative breast cancer cells via a membrane-associated mechanism.

Chaudhri RA, Hadadi A, Lobachev KS, Schwartz Z, Boyan BD.

Biochim Biophys Acta. 2014 Nov;1843(11):2796-806. doi: 10.1016/j.bbamcr.2014.07.019. Epub 2014 Aug 7.

16.

Older women's experience with breast cancer treatment decisions.

Schonberg MA, Birdwell RL, Bychkovsky BL, Hintz L, Fein-Zachary V, Wertheimer MD, Silliman RA.

Breast Cancer Res Treat. 2014 May;145(1):211-23. doi: 10.1007/s10549-014-2921-y. Epub 2014 Mar 31.

17.

Dedicated 3D photoacoustic breast imaging.

Kruger RA, Kuzmiak CM, Lam RB, Reinecke DR, Del Rio SP, Steed D.

Med Phys. 2013 Nov;40(11):113301. doi: 10.1118/1.4824317.

18.

Reproductive factors and risk of premenopausal breast cancer by age at diagnosis: are there differences before and after age 40?

Warner ET, Colditz GA, Palmer JR, Partridge AH, Rosner BA, Tamimi RM.

Breast Cancer Res Treat. 2013 Nov;142(1):165-75. doi: 10.1007/s10549-013-2721-9. Epub 2013 Oct 18.

19.

Trends in breast cancer stage and mortality in Michigan (1992-2009) by race, socioeconomic status, and area healthcare resources.

Akinyemiju TF, Soliman AS, Copeland G, Banerjee M, Schwartz K, Merajver SD.

PLoS One. 2013 Apr 29;8(4):e61879. doi: 10.1371/journal.pone.0061879. Print 2013.

20.

Dietary intake of folate, B-vitamins and methionine and breast cancer risk among Hispanic and non-Hispanic white women.

Yang D, Baumgartner RN, Slattery ML, Wang C, Giuliano AR, Murtaugh MA, Risendal BC, Byers T, Baumgartner KB.

PLoS One. 2013;8(2):e54495. doi: 10.1371/journal.pone.0054495. Epub 2013 Feb 11.

Items per page

Supplemental Content

Write to the Help Desk